(Q44188017)

English

In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients

scientific article published in November 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Alzheimer's disease

0 references

0 references

author name string

Takekazu Kubo

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Satoko Nishimura

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Yoshihiro Kumagae

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Isao Kaneko

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

publication date

1 November 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Journal of Neuroscience Research

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

70

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

474-483

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Methods for staining amyloid in tissues: a review

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Drastic neuronal loss in vivo by beta-amyloid racemized at Ser(26) residue: conversion of non-toxic [D-Ser(26)]beta-amyloid 1-40 to toxic and proteinase-resistant fragments

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Chemical modifications of deposited amyloid-beta peptides

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Co-injection of beta-amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Alzheimer's disease: a re-examination of the amyloid hypothesis

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Alzheimer's disease as proteolytic disorders: anabolism and catabolism of beta-amyloid

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Biochemistry of altered brain proteins in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Neuritic plaque amyloid in Alzheimer's disease is highly racemized

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10391

21 January 2018

Identifiers

10.1002/JNR.10391

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44188017&oldid=2108358176"